With more than half of all cases pending in the federal courts now docketed in multidistrict litigations (MDLs), pharmaceutical and medical device companies facing large-scale litigation should expect to find themselves before the Judicial Panel on Multidistrict Litigation (JPML) with an MDL on the horizon.
That’s why Melissa Geist and Jennifer Eppensteiner are pleased to present a free CLE webinar on “Multidistrict Litigation: What to Expect from JPML Consolidation Through Trial.” This webinar will provide in-house counsel at life sciences companies with an introduction to JPML and MDL procedures, including the latest trends and strategic tips for maximizing efficiencies where possible. You will also learn about the effect MDL litigation can have on pending state court actions, as well as about best practices for coordination among federal and state court actions.
This program is presumptively approved for 1.0 general CLE credit in California, Illinois, New Jersey, Pennsylvania, Texas and West Virginia. For lawyers licensed in New York, this course is eligible for 1.0 credit under New York’s Approved Jurisdiction Policy.
To register for this free webinar, please click here.